These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17673802)

  • 21. Thrombolysis at 3-4.5 hours after acute ischemic stroke onset--evidence from the Canadian Alteplase for Stroke Effectiveness Study (CASES) registry.
    Shobha N; Buchan AM; Hill MD;
    Cerebrovasc Dis; 2011; 31(3):223-8. PubMed ID: 21178345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic thrombolysis in clinical practice: what have we learned after the Safe Implementation of Thrombolysis in Stroke Monitoring Study?
    Wahlgren N
    Cerebrovasc Dis; 2009; 27 Suppl 1():168-76. PubMed ID: 19342848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombolysis for stroke.
    Fitzgerald M; Gerraty RP
    Med J Aust; 2010 Oct; 193(8):436-7. PubMed ID: 20955117
    [No Abstract]   [Full Text] [Related]  

  • 24. Community-based thrombolytic therapy of acute ischemic stroke in Helsinki.
    Lindsberg PJ; Soinne L; Roine RO; Salonen O; Tatlisumak T; Kallela M; Häppölä O; Tiainen M; Haapaniemi E; Kuisma M; Kaste M
    Stroke; 2003 Jun; 34(6):1443-9. PubMed ID: 12738891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombolysis for stroke in the over 80s.
    Ford GA
    Age Ageing; 2004 Mar; 33(2):95-7. PubMed ID: 14960420
    [No Abstract]   [Full Text] [Related]  

  • 26. Stroke mimics treated with thrombolysis: further evidence on safety and distinctive clinical features.
    Guillan M; Alonso-Canovas A; Gonzalez-Valcarcel J; Garcia Barragan N; Garcia Caldentey J; Hernandez-Medrano I; Defelipe-Mimbrera A; Sanchez-Gonzalez V; Terecoasa E; Alonso de Leciñana M; Masjuan J
    Cerebrovasc Dis; 2012; 34(2):115-20. PubMed ID: 22854315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and outcomes following thrombolytic treatment in stroke patients who had received prior treatment with anticoagulants.
    Matute MC; Masjuan J; Egido JA; Fuentes B; Simal P; Díaz-Otero F; Reig G; Díez-Tejedor E; Gil-Nuñez A; Vivancos J; Alonso de Leciñana M
    Cerebrovasc Dis; 2012; 33(3):231-9. PubMed ID: 22261670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of recombinant plasminogen activator timing on thrombolysis in a novel rat embolic stroke model.
    Ma Y; Li L; Niu Z; Song J; Lin Y; Zhang H; Du G
    Pharmacol Res; 2016 May; 107():291-299. PubMed ID: 27038532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subarachnoid hemorrhage--a rare complication after intravenous thrombolysis in an ischemic stroke patient.
    Chou CL; Lin YJ; Po HL; Chang CK
    Am J Emerg Med; 2010 Oct; 28(8):984.e1-3. PubMed ID: 20825835
    [No Abstract]   [Full Text] [Related]  

  • 30. Risks and benefits of thrombolysis in the elderly.
    Asdaghi N; Butcher KS; Hill MD
    Int J Stroke; 2012 Feb; 7(2):142-9. PubMed ID: 22264367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of early blood pressure variability on stroke outcomes after thrombolysis: the SAMURAI rt-PA Registry.
    Endo K; Kario K; Koga M; Nakagawara J; Shiokawa Y; Yamagami H; Furui E; Kimura K; Hasegawa Y; Okada Y; Okuda S; Namekawa M; Miyagi T; Osaki M; Minematsu K; Toyoda K
    Stroke; 2013 Mar; 44(3):816-8. PubMed ID: 23329210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The iScore predicts effectiveness of thrombolytic therapy for acute ischemic stroke.
    Saposnik G; Fang J; Kapral MK; Tu JV; Mamdani M; Austin P; Johnston SC; ;
    Stroke; 2012 May; 43(5):1315-22. PubMed ID: 22308252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Barriers to delivery of thrombolysis for acute stroke.
    Barber M; Langhorne P; Stott DJ
    Age Ageing; 2004 Mar; 33(2):94-5. PubMed ID: 14960419
    [No Abstract]   [Full Text] [Related]  

  • 35. The SITS-MOST registry.
    Toni D; Lorenzano S; Puca E; Prencipe M
    Neurol Sci; 2006 Jun; 27 Suppl 3():S260-2. PubMed ID: 16752063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Thrombolytic therapy for acute ischemic stroke. Experience of SITS (Safe Implementation of Thrombolysis in Stroke) register].
    Rodríguez-Yáñez M; Alvarez-Sabín J; Dávalos A; Díez-Tejedor E; Castillo J
    Neurologia; 2009 Jun; 24(5):288-91. PubMed ID: 19642029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous Thrombolysis for Stroke Recurring Within 3 Months From the Previous Event.
    Karlinski M; Kobayashi A; Czlonkowska A; Mikulik R; Vaclavik D; Brozman M; Gdovinova Z; Švigelj V; Csiba L; Fekete K; Kõrv J; Demarin V; Bašic-Kes V; Vilionskis A; Jatuzis D; Krespi Y; Shamalov N; Andonova S; Ahmed N; Wahlgren N;
    Stroke; 2015 Nov; 46(11):3184-9. PubMed ID: 26451024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. tPA in daily clinical practice.
    Nighoghossian N
    Stroke; 2003 May; 34(5):1106-13. PubMed ID: 12733503
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of acute ischaemic stroke with thrombolysis or thrombectomy in patients receiving anti-thrombotic treatment.
    Diener HC; Foerch C; Riess H; Röther J; Schroth G; Weber R
    Lancet Neurol; 2013 Jul; 12(7):677-88. PubMed ID: 23726849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
    Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
    Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.